• $7.4M
    Market Cap
  • -96.32%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
Income Statement
Total Operating Revenue
N/A
N/A
Cost of Revenue
N/A
N/A
Gross Profit
0
N/A
Sales and Marketing Expense
N/A
N/A
Research and Development Expense
-2.7M
N/A
Depreciation and Amortization Expense
1,828
N/A
Total Operating Expenses
3.0M
N/A
Operating Profit
-3.0M
N/A
Interest Income
76,589
N/A
Interest Expense
-35,023
N/A
Interest Income and Expense and Net
41,566
N/A
Total Nonoperating Income and Expense
-7.2M
N/A
Income before Taxes
-3.0M
N/A
Income Taxes
N/A
N/A
Extraordinary Items
N/A
N/A
Net Income
-10.2M
N/A
Net Income from Continuing Operations Applicable to Common
-10.2M
N/A
Basic EPS and Net Income
-0.43
N/A
Diluted EPS and Net Income
-0.43
N/A
Basic Weighted Average Shares
23.8M
N/A
Diluted Weighted Average Shares
23.8M
N/A
Balance Sheet
Cash and Cash Equivalents
337,655
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
337,655
N/A
Total Current Assets
500,574
N/A
Accumulated Depreciation
N/A
N/A
Property and Plant and Equipment and Net
12,221
N/A
Total Long-Term Assets
12,221
N/A
Total Assets
512,795
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
1.4M
N/A
Total Current Liabilities
10.3M
N/A
Total Long-Term Debt
N/A
N/A
Total Long-Term Liabilities
0
N/A
Total Liabilities
10.3M
N/A
Retained Earnings
-38.9M
N/A
Total Stockholders Equity
-9.8M
N/A
Total Shares Outstanding
27.1M
N/A
Cash Flow
Cash from Operating Activities
-10.0M
N/A
Capital Expenditures
13,108
N/A
Cash from Investing Activities
-788,108
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
11.0M
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow